PICKERING, ON, Jan. 27, 2014 /CNW/ – Purdue Pharma Canada today announced the appointment of David A. Pidduck to the position of Vice President, Marketing and Health Solutions, effective January 27, 2014. In this role, Mr. Pidduck will be responsible for leading all sales and marketing activities and will be a key member of Purdue’s executive leadership team, reporting to Dr. Craig Landau, President and CEO.
Mr. Pidduck earned his MBA from the Kellogg School of Management and comes to Purdue with many years of commercial experience in the pharmaceutical, drug delivery and device industries. He spent over 25 years at Baxter, most recently as Vice President for Baxter’s Medication Delivery business in Europe, based in Zurich, Switzerland. In his career at Baxter, David held multiple executive roles within the corporate and regional businesses, and led several Canadian business units. His experience spans many disciplines, including Sales, Marketing, Finance, Business Development, and Corporate Strategy.
According to Dr. Landau: “David’s experience in Canada, the U.S. and Europe will provide valuable business and organizational perspectives, and will help Purdue further its position as the leading innovative analgesic pharmaceutical company in Canada. Further, David will be a key contributor to Purdue’s business diversification strategy going forward, in keeping with our goal of bringing health benefits to Canadian patients through innovative products.”
About Purdue Pharma (Canada)
Purdue Pharma (www.purdue.ca) is a research-based pharmaceutical company with its headquarters and manufacturing operations located in Pickering, Ontario. The company is a leader in the research and development of medicines for the treatment of pain. Privately held, Purdue Pharma Canada is independently associated with the worldwide Purdue/Napp/Mundipharma group of companies.